Additive Effect of Twice-daily Brinzolamide 1% / Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma

Condition:   Glaucoma Interventions:   Drug: brinzolamide 1% / brimonidine 0.2%;   Drug: Placebo Sponsor:   Novartis Pharmaceuticals Not yet recruiting - verified May 2017

Source: ClinicalTrials.gov - May 9, 2017 Category: Research Source Type: clinical trials